Introduction
Lichen planus is a chronic inflammatory condition in which the immune system targets cells in the skin and mucous membranes, especially the outer layer of the epidermis and the lining of the mouth or genital tract. It is not an infection and not a simple rash; it is an immune-mediated disorder in which T cells attack the basal layer of epithelial tissue, leading to interface inflammation and damage to the cells that anchor and maintain the surface lining. The result is a characteristic pattern of tissue injury that can involve skin, oral mucosa, nails, scalp, and, less commonly, other mucosal surfaces.
At a biological level, lichen planus reflects a breakdown in immune tolerance. For reasons that are not fully understood, the body identifies certain cells in the basal epidermis or mucosal epithelium as targets. This triggers a localized inflammatory response driven mainly by cytotoxic T lymphocytes, cytokines, and apoptosis of epithelial cells. Understanding lichen planus therefore requires understanding both the structure of the affected tissues and the immune processes that destabilize them.
The Body Structures or Systems Involved
The structures most often involved are the skin and the stratified squamous epithelium lining the mouth, genitalia, and other mucosal sites. In healthy skin, the epidermis forms a layered protective barrier. Its deepest layer, the basal layer, contains cells that continually divide and replenish the surface. These cells are attached to the basement membrane, a specialized structure that helps maintain the integrity of the epidermis and regulates communication between epithelial cells and the underlying dermis.
The oral and genital mucosa have a similar layered epithelial architecture, although they are adapted for moisture, mechanical stress, and rapid renewal. These surfaces normally remain smooth, intact, and selectively permeable, allowing them to protect underlying tissues while tolerating friction, saliva, secretions, and microbial exposure. In lichen planus, these tissues become the main site of disease because their basal epithelial cells are recognized and attacked by immune cells.
The immune system is the other major system involved. Lichen planus is driven by cell-mediated immunity rather than by antibody deposition alone. Activated T cells, especially CD8-positive cytotoxic T cells, accumulate near the basal epithelial layer. These immune cells release inflammatory mediators and induce injury in the epithelial cells that maintain the surface lining. Local vascular and connective tissue changes also occur, but the initiating event is centered on epithelial-immune interaction.
How the Condition Develops
Lichen planus develops when immune surveillance becomes misdirected toward cells in the basal layer of the epithelium. In a healthy state, immune cells patrol tissues to detect infection, abnormal cells, or signs of damage. In lichen planus, antigen presentation or immune regulation appears to go wrong, causing basal keratinocytes or mucosal epithelial cells to be treated as abnormal. The exact trigger is not always identifiable, but the downstream process is fairly consistent: T cells become activated, migrate into the tissue, and concentrate along the junction between epithelium and the underlying connective tissue.
Once there, the immune cells release cytokines such as interferon-gamma and tumor necrosis factor, which amplify the inflammatory response and attract additional lymphocytes. Cytotoxic T cells also induce apoptosis in basal epithelial cells through direct cell-killing mechanisms. This creates a band-like infiltrate of inflammatory cells beneath the epithelium and damages the basal layer that anchors the surface tissue. Because the basal cells are essential for maintaining epithelial renewal and structural cohesion, their injury destabilizes the entire tissue architecture.
The process is often described as an interface dermatitis when it affects skin, meaning the inflammation is concentrated at the interface between epidermis and dermis. In the mouth and other mucosal sites, a similar interface mucositis occurs. The damaged basal cells lead to altered maturation of the overlying epithelium, with changes in thickness, surface texture, and cell turnover. The tissue may become hyperkeratotic in some areas, meaning the outer keratin layer thickens in response to chronic irritation and repair signals, while in other areas the epithelial surface becomes thinned or eroded because cell loss outpaces replacement.
As the condition persists, the immune response becomes self-sustaining. Injury to epithelial cells exposes additional antigens and danger signals, which further stimulate local inflammation. The tissue therefore enters a cycle of immune activation, epithelial damage, and attempted repair. This explains why lichen planus can be persistent and why lesions may remain active for long periods rather than resolving quickly.
Structural or Functional Changes Caused by the Condition
The central structural change in lichen planus is injury to the basal epithelial layer. When these cells are damaged or lost, the interface between epithelium and underlying connective tissue becomes unstable. In skin, this can alter the normal layering of the epidermis and produce a compact, thickened surface layer or, in some forms, thinning and fragility. The dermoepidermal junction may show degeneration of basal cells, a phenomenon sometimes called vacuolar change, in which the basal cell layer becomes structurally disrupted.
Another characteristic change is the accumulation of inflammatory cells in a dense, band-like pattern just beneath the epithelium. This infiltrate alters local tissue architecture and interferes with normal epithelial regeneration. The immune response also prompts pigmentary changes in the skin. When basal keratinocytes are damaged, melanin from the epidermis can be released into the dermis and taken up by macrophages, creating residual hyperpigmentation after active inflammation subsides.
In the oral cavity, functional changes affect the protective and mechanical properties of the mucosa. The surface may become irregular, inflamed, or eroded because the epithelium cannot maintain stable cohesion. Saliva, speech, chewing, and contact with foods can then interact with the altered mucosa more intensely, making the tissue mechanically vulnerable. On the tongue, gingiva, or buccal mucosa, this disruption can impair barrier function and make the epithelium more reactive to minor trauma.
Nail and scalp involvement reflects the same principle in different structures. In nails, inflammation can interfere with normal nail matrix function, disrupting keratin production and nail plate formation. In the scalp, inflammation directed at follicular epithelium can affect hair-bearing units and, in some cases, produce scarring if the follicle is permanently damaged. Across these sites, the key functional problem is the same: immune injury to epithelial structures that normally depend on steady renewal and intact anchoring to preserve surface integrity.
Factors That Influence the Development of the Condition
Several factors influence whether lichen planus develops, but the disorder is not usually explained by one single cause. The strongest theme is immune dysregulation. The disease appears to arise when local or systemic immune control fails to prevent T-cell activation against epithelial targets. Genetic susceptibility likely contributes to this tendency by shaping immune responsiveness, antigen presentation, and inflammatory set points. Some people may have immune systems that are more prone to overreact to self-derived or altered-self antigens in epithelial tissue.
Environmental and external factors can also modulate disease activity. Certain viral infections, especially hepatitis C in some populations, have been associated with lichen planus, suggesting that chronic immune stimulation or viral cross-reactivity may participate in disease initiation in susceptible individuals. Other triggers may include medications that produce lichenoid reactions, dental materials, or chronic mucosal irritation, all of which can alter epithelial antigens or provoke local immune activation. These factors do not create the same condition in every person, but they can shift the balance toward inflammation in predisposed tissues.
The role of stress, while often discussed in broad terms, is better understood as a modifier of immune and neuroendocrine signaling. Persistent stress can influence cytokine production, barrier repair, and immune regulation, potentially changing how active the inflammatory process becomes. Hormonal factors may also affect mucosal and skin immunity, although they are not a primary explanation for the disease. In general, lichen planus emerges when a vulnerable epithelial surface meets an immune system that has become excessively reactive or poorly regulated.
Variations or Forms of the Condition
Lichen planus is not a single uniform pattern. It can appear in several forms depending on which tissue is affected and how intense the immune injury is. Cutaneous lichen planus involves the skin and typically reflects the classic interface inflammation of the epidermis. Oral lichen planus affects the lining of the mouth and may be confined to the mucosa, sometimes persisting even when skin lesions are absent. Genital lichen planus can affect the vulva, vagina, or penis and often behaves similarly to oral disease because these are also stratified squamous mucosal surfaces.
There are also morphologic variants that reflect differences in the balance between inflammation, epithelial thickening, and tissue injury. Some forms are more papular and thickened, indicating a strong hyperplastic response of the epidermis. Others are erosive or atrophic, showing greater epithelial loss and surface breakdown. Hypertrophic forms develop when chronic immune stimulation drives marked thickening of the skin, while annular or linear patterns reflect the distribution of inflammatory activity along specific tissue planes or sites of irritation.
In the hair-bearing scalp, a related condition called lichen planopilaris targets the follicular epithelium rather than the interfollicular skin. This form matters because the immune attack can destroy the follicle’s regenerative capacity, making the outcome more structural than superficial. Thus, the different forms of lichen planus arise from the same immune mechanism, but the final appearance depends on the tissue architecture, the depth of injury, and the degree of epithelial regeneration versus destruction.
How the Condition Affects the Body Over Time
When lichen planus persists, the immune response may continue to remodel tissue even if the condition remains localized. Repeated cycles of epithelial injury and repair can thicken some tissues, thin others, and leave behind pigmentary or textural changes. In skin, this may produce lingering post-inflammatory pigmentation because melanotic debris remains in the dermis after the active inflammation subsides. In mucosal tissue, chronic inflammation can alter the surface architecture and make the epithelium more prone to minor breakdown under friction or chemical exposure.
Long-term inflammation also changes the microenvironment of the tissue. Cytokine signaling, immune-cell recruitment, and local repair processes can shift the balance between regeneration and damage. If the basal layer is repeatedly injured, the epithelial stem-cell pool may be stressed, reducing the tissue’s ability to maintain normal renewal. In scarring variants, especially on the scalp, permanent structural damage can occur when the follicular epithelium is destroyed and replaced by fibrous tissue.
Another long-term issue is that chronic mucosal lichen planus can remain active for years, reflecting ongoing immune recognition of the epithelial target. The body may partially adapt through remodeling, but it does not necessarily restore normal tolerance. In some settings, chronic inflammation may also create a setting in which dysplasia is more likely to be monitored closely, particularly in persistent erosive oral disease. This risk is tied to prolonged epithelial turnover and inflammatory stress rather than to simple surface irritation.
Conclusion
Lichen planus is a chronic immune-mediated disorder that primarily affects the skin and mucous membranes by targeting the basal epithelial layer. Its core biology involves T-cell-driven inflammation at the interface between epithelium and underlying tissue, leading to apoptosis of basal cells, disruption of tissue architecture, and altered epithelial renewal. The disease can appear in several forms because the same immune mechanism acts on different epithelial structures with different patterns of repair and vulnerability.
Understanding lichen planus at the level of tissue structure and immune function clarifies why it behaves as a persistent inflammatory condition rather than a simple surface rash. The disorder reflects a defect in immune regulation, epithelial stability, and local tissue repair. Those mechanisms explain both its variable appearance and its tendency to recur or persist over time.